SCHEMBL1469801

SCHEMBL1469801

NCCc1ccc2oc(=O)[nH]c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.53
NOS3 P29474 3/20 0.53
NOS2 P35228 3/20 0.53
ADRA2A P08913 2/20 0.53
THPO P40225 2/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
TSHR P16473 1/20 0.53
BLM P54132 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
OGT O15294 1/20 0.46
POLB P06746 1/20 0.46
KMO O15229 1/20 0.43
PDE10A Q9Y233 2/20 0.43
KCNH2 Q12809 1/20 0.39
MCHR2 Q969V1 1/20 0.39
MCHR1 Q99705 1/20 0.39
HTR1A P08908 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6023537 0.87 NOS1 (0.53) NOS1NOS3NOS2ADRA2ATHPO
SCHEMBL8186885 0.86 NOS1 (0.56) NOS1NOS3NOS2ADRA2ATHPO
SCHEMBL5544121 0.83 NOS1 (0.53) NOS1NOS3NOS2ADRA2ATHPO
SCHEMBL5657894 0.83 POLB (0.56) NOS1NOS3NOS2ADRA2ATHPO
SCHEMBL21439486 0.81 NOS1 (0.47) NOS1NOS3NOS2ADRA2ATHPO
SCHEMBL5543089 0.81 NOS1 (0.50) NOS1NOS3NOS2ADRA2ATHPO
SCHEMBL5491863 0.80 NOS1 (0.53) NOS1NOS3NOS2ADRA2ATHPO
SCHEMBL5543895 0.80 NOS1 (0.49) NOS1NOS3NOS2ADRA2ATHPO
SCHEMBL7903542 0.79 NOS1 (0.61) NOS1NOS3NOS2ADRA2ATHPO
SCHEMBL5542404 0.79 NOS1 (0.56) NOS1NOS3NOS2ADRA2ATHPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268822-B2 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-09-18 US disclosed
US-20110071134-A1 2-(AMINO-SUBSTITUTED)-4-ARYL PYRIMIDINES AND RELATED COMPOUNDS USEFUL FOR TREATING INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-03-24 US disclosed
US-7732444-B2 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-06-08 US disclosed
EP-2123647-A1 2-(amino-substituted)-4-phenyl pyrimidines useful for treating inflammatory diseases Millennium Pharmaceuticals, Inc. (US) 2009-11-25 EP disclosed
EP-1701944-B1 2-(AMINO-SUBSTITUTED)-4-ARYL PYRAMIDINES AND RELATED COMPOUNDS USEFUL FOR TREATING INFLAMMATORY DISEASES MILLENNIUM PHARM INC (US) 2009-07-29 EP disclosed
US-20060040968-A1 2-(Amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases MILLENNIUM PHARMACEUTICALS, INC. 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071134-A1 2-(AMINO-SUBSTITUTED)-4-ARYL PYRIMIDINES AND RELATED COMPOUNDS USEFUL FOR TREATING INFLAMMATORY DISEASES PRKCZ, PRKCQ, PRKCE NOS1 287/4885NOS3 331/4885NOS2 281/4885
US-20060040968-A1 2-(Amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases PRKCZ, PRKCQ, PRKCE NOS1 287/4885NOS3 331/4885NOS2 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.